Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101929552 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C1orf168 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMEM37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LRRIQ3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXA-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNGB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EZR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCAT18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HECA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LACE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCAN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927482 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NACAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on